JP2006219433A - Agent for preventing ultraviolet hazard - Google Patents
Agent for preventing ultraviolet hazard Download PDFInfo
- Publication number
- JP2006219433A JP2006219433A JP2005035234A JP2005035234A JP2006219433A JP 2006219433 A JP2006219433 A JP 2006219433A JP 2005035234 A JP2005035234 A JP 2005035234A JP 2005035234 A JP2005035234 A JP 2005035234A JP 2006219433 A JP2006219433 A JP 2006219433A
- Authority
- JP
- Japan
- Prior art keywords
- aqueous solution
- olive fruit
- ultraviolet
- solution part
- squeezing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003405 preventing effect Effects 0.000 title abstract description 8
- 240000007817 Olea europaea Species 0.000 claims abstract description 39
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 39
- 239000007864 aqueous solution Substances 0.000 claims abstract description 34
- 239000000284 extract Substances 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 17
- 239000003960 organic solvent Substances 0.000 claims abstract description 11
- 239000007787 solid Substances 0.000 claims abstract description 7
- 230000006378 damage Effects 0.000 claims description 25
- 208000027418 Wounds and injury Diseases 0.000 claims description 20
- 208000014674 injury Diseases 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 18
- 239000007790 solid phase Substances 0.000 claims description 15
- 230000003449 preventive effect Effects 0.000 claims description 13
- 235000013305 food Nutrition 0.000 claims description 12
- 238000003825 pressing Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims 1
- 230000037406 food intake Effects 0.000 abstract description 7
- 206010015150 Erythema Diseases 0.000 abstract description 6
- 231100000321 erythema Toxicity 0.000 abstract description 6
- 206010030113 Oedema Diseases 0.000 abstract description 3
- 230000037303 wrinkles Effects 0.000 abstract description 3
- 239000000243 solution Substances 0.000 abstract description 2
- 230000008719 thickening Effects 0.000 abstract description 2
- 230000005856 abnormality Effects 0.000 abstract 1
- 230000019612 pigmentation Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 description 26
- 239000000047 product Substances 0.000 description 20
- 238000002156 mixing Methods 0.000 description 19
- 238000007796 conventional method Methods 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 235000013361 beverage Nutrition 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 229920001353 Dextrin Polymers 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 235000008504 concentrate Nutrition 0.000 description 5
- 235000019425 dextrin Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- -1 that is Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000208251 Gymnema Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040867 Skin hypertrophy Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 230000004565 tumor cell growth Effects 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2131—Olive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Abstract
Description
本発明はオリーブの果実を圧搾して得られる水溶液部、又はオリーブの果実を圧搾して得られる水溶液部及び固相部より水及び/又は有機溶媒を用い抽出して得られる抽出物を含有して得られる紫外線傷害予防剤に関する。 The present invention contains an aqueous solution part obtained by squeezing olive fruit, or an extract obtained by extracting water and / or an organic solvent from an aqueous solution part obtained by squeezing olive fruit and a solid phase part. It is related with the ultraviolet-ray injury preventive agent obtained by this.
皮膚が紫外線に暴露されると紅斑や浮腫など様々な傷害が発生し、さらに皮膚の肥厚や弾性喪失、シワの発生、色素沈着異常など光老化現象が引き起こされると考えられている。そして強い紫外線の繰り返しの暴露は、皮膚がんのリスクを増大させることが知られている。これまで紫外線による傷害を防御するには、これを遮断する皮膚外用剤の塗布が主な手段とされていた。しかしながら、上記皮膚外用剤を身体の露出部分に外出の度に完全に塗布することは手間と時間がかかること、また発汗や水に触れることにより外用剤が落ち、その効果が消失することから、より手軽で有効な紫外線対策の手段が望まれていた。 When skin is exposed to ultraviolet rays, various injuries such as erythema and edema occur, and it is also considered that photoaging phenomena such as skin thickening and loss of elasticity, generation of wrinkles and abnormal pigmentation are caused. And repeated exposure to intense UV radiation is known to increase the risk of skin cancer. Until now, in order to protect against the damage caused by ultraviolet rays, the application of an external preparation for skin that blocks the damage has been the main means. However, it is time-consuming and time-consuming to apply the above-mentioned external preparation for skin to the exposed part of the body every time it goes out, and since the external preparation falls by touching sweat or water, the effect disappears. A simpler and more effective means for preventing ultraviolet rays has been desired.
そこで紫外線による皮膚の傷害を軽減することを目的に、経口摂取によって皮膚を紫外線から保護する効果のある薬理成分について、多くの研究がなされている。例えば、ヒトがカロチノイドやビタミンEを経口摂取することにより、紫外線により誘発される皮膚の炎症(紅斑)が抑制されたという報告がなされている(非特許文献1、2参照)。 Therefore, many studies have been conducted on pharmacological components that have an effect of protecting the skin from ultraviolet rays by ingestion with the aim of reducing skin damage caused by ultraviolet rays. For example, it has been reported that human ingestion of carotenoids and vitamin E has suppressed skin inflammation (erythema) induced by ultraviolet rays (see Non-Patent Documents 1 and 2).
一方、オリーブ(Olea europaea L.)植物由来の抽出物には抗酸化能、メラニン生成抑制、腫瘍細胞増殖抑制・死滅機能など種々の生理活性が見出されている(特許文献1、23参照)。またオリーブの果実から得られるベジテーション水を含有することを特徴とする皮膚化粧料、頭髪化粧料、食品組成物は、すでに特許出願されている(特許文献4、5、6参照)。そしてラットにベジテーション水の抽出物を経口投与することで、血漿の抗酸化活性が高まることや、副流煙暴露によって誘発されるDNA酸化損傷マーカー量が減少することが見出されている(非特許文献3、4参照)。
On the other hand, olive (Olea europaea L.) plant-derived extracts have been found to have various physiological activities such as antioxidant ability, melanin production inhibition, tumor cell growth inhibition / killing function (see Patent Documents 1 and 23). . In addition, patent applications have already been filed for skin cosmetics, hair cosmetics, and food compositions containing vegetation water obtained from olive fruit (see Patent Documents 4, 5, and 6). And it has been found that oral administration of vegetation water extract to rats increases plasma antioxidant activity and reduces the amount of DNA oxidative damage marker induced by sidestream smoke exposure ( Non-Patent
しかしながら、オリーブの果実を圧搾して得られる水溶液部、又はオリーブの果実を圧搾して得られる水溶液部及び固相部より水及び/又は有機溶媒を用い抽出して得られる抽出物の経口摂取によって、ヒトの皮膚を紫外線の傷害から保護する効果はいまだ検討されていない。 However, by ingestion of an extract obtained by extracting water and / or an organic solvent from an aqueous solution part obtained by pressing olive fruit, or an aqueous solution part obtained by pressing olive fruit and a solid phase part. The effect of protecting human skin from UV damage has not yet been investigated.
本発明の目的は、皮膚が紫外線に暴露されることにより誘発される紅斑や浮腫、さらには皮膚の肥厚や弾性喪失、シワの発生、色素沈着異常などを効果的に予防する、経口摂取による手段を提供することにある。 It is an object of the present invention to effectively prevent erythema and edema induced by exposure of the skin to ultraviolet rays, as well as thickening and loss of elasticity of the skin, generation of wrinkles, abnormal pigmentation, etc. Is to provide.
そこで本発明者等は上記事情に鑑み、鋭意研究した結果、オリーブの果実を圧搾して得られる水溶液部、又はオリーブの果実を圧搾して得られる水溶液部及び固相部より水及び/又は有機溶媒を用い抽出して得られる抽出物(以下「オリーブ果実抽出物等」と略記することがある。)を有効量経口摂取することで、優れた紫外線傷害予防効果が発揮されることを見出し、本発明を完成させるに到った。即ち、本発明は、「オリーブ果実抽出物等」を含有することを特徴とする、紫外線傷害予防剤にある。 In view of the above circumstances, the present inventors have intensively studied, and as a result, obtained water and / or organic from an aqueous solution part obtained by squeezing olive fruit, or an aqueous solution part obtained by squeezing olive fruit and a solid phase part. It has been found that by taking an effective amount of an extract obtained by extraction with a solvent (hereinafter sometimes abbreviated as “olive fruit extract etc.”) orally, an excellent ultraviolet damage prevention effect is exhibited, The present invention has been completed. That is, the present invention resides in an ultraviolet ray injury preventive agent characterized by containing “olive fruit extract and the like”.
また、本発明は、前記紫外線傷害予防剤を配合した飲食品組成物、特に「オリーブ果実抽出物等」として、乾固物換算で0.01〜70質量%配合した飲食品組成物にあり、さらに、「オリーブ果実抽出物等」を、1日当たり、乾固物換算で0.05〜1.0g摂取させる方法にある。 In addition, the present invention is a food / beverage composition containing the ultraviolet ray injury preventive agent, particularly as an “olive fruit extract etc.” in a food / beverage composition containing 0.01 to 70% by mass in terms of dry matter, Furthermore, there is a method of ingesting 0.05 to 1.0 g of “olive fruit extract or the like” per day in terms of dry matter.
本発明の紫外線傷害予防剤は、経口摂取により効果的に紫外線照射が原因となる皮膚傷害を予防できる。本発明の紫外線傷害予防剤はオリーブの果実を圧搾して得られる水溶液部や固相部より容易に得ることができ、且つオリーブ油の生産過程における不要物由来であり、大量に廃棄されていることから、安価に安定供給ができる特徴がある。また、本発明の紫外線傷害予防剤を摂取させる方法によれば、紫外線傷害予防効果を特に効率良く達成させることが可能である。 The UV injury preventive agent of the present invention can effectively prevent skin injury caused by UV irradiation by ingestion. The UV injury preventive agent of the present invention can be easily obtained from an aqueous solution part or a solid phase part obtained by squeezing olive fruit, and is derived from unnecessary substances in the production process of olive oil and discarded in large quantities. Therefore, there is a feature that can be stably supplied at low cost. In addition, according to the method of ingesting the UV injury preventive agent of the present invention, the UV injury prevention effect can be achieved particularly efficiently.
本発明の原料に用いるオリーブ果実および品種は、国産、欧州産、食用、搾油用を問わず使用できるが、Coratina種であることが好ましい。また、オリーブ果実としては、果皮、果肉部、種子を合わせた全体を使用するが、果皮や種子が除かれていても構わない。 The olive fruits and varieties used in the raw material of the present invention can be used regardless of whether they are domestically produced, Europeanly produced, edible or oiled, but are preferably Coratina species. Further, as the olive fruit, the whole fruit skin, flesh part, and seed are used together, but the fruit skin and seed may be removed.
本発明に用いるオリーブの果実を圧搾して得られる水溶液部は、オリーブ油の製造における圧搾工程中で副産物として得られる。また、この水溶液部はベジテーション水などとも呼ばれる。水溶液部は、得られたものを直接用いることも可能であるが、混入する脂質成分、繊維質成分や種子殻等を濾過や遠心分離を行うことにより除去、精製して用いることが好ましい。また雑菌の混入による異臭の発生等を抑える目的で、ベジテーション水または水溶液部に、エチルアルコール、イソプロピルアルコール、1,3−ブチレングリコール、プロピレングリコール等の親水性のアルコール類や多価アルコールを、総量中に好ましくは5〜80質量%、特に好ましくは10〜40質量%の量になるように添加した後に、濾過や遠心分離等により分離精製することが特に好ましい。また、得られた水溶液部等又はその分離精製したものを定法により濃縮又は乾固させて用いることもできる。 The aqueous solution part obtained by pressing the olive fruit used in the present invention is obtained as a by-product during the pressing process in the production of olive oil. Moreover, this aqueous solution part is also called vegetation water. The obtained aqueous solution part can be used directly, but it is preferable to use it after removing and purifying the lipid component, fiber component, seed shell and the like mixed by filtration or centrifugation. In addition, for the purpose of suppressing the generation of off-flavors due to contamination with germs, hydrophilic alcohols such as ethyl alcohol, isopropyl alcohol, 1,3-butylene glycol, propylene glycol and polyhydric alcohols are added to the vegetation water or aqueous solution. It is particularly preferable that the total amount is preferably 5 to 80% by mass, and particularly preferably 10 to 40% by mass, followed by separation and purification by filtration or centrifugation. Further, the obtained aqueous solution portion or the like or a product obtained by separation and purification thereof can be used by concentrating or drying by a conventional method.
一方、オリーブの果実を圧搾して得られる固相部とは、オリーブ果実の圧搾工程で得られる液相部以外の圧搾残渣を指す。本発明では、前記水溶液部及び固相部に、水及び/又は有機溶媒を抽出溶媒として得られる抽出液を、本発明の抽出物としてを使用する。好ましい有機溶媒としては、エチルアルコール、イソプロピルアルコール、1,3−ブチレングリコール、プロピレングリコール等の親水性のアルコール類や多価アルコール類等であり、また、これらの有機溶媒と水との混合溶媒を使用することも可能である。得られた抽出液は直接用いることも可能であるが、分離精製したものを定法により濃縮または乾固させたものを用いることもできる。尚、オリーブの果実を圧搾して得られる固相部から上記抽出法により得られる抽出物も、本発明の水溶液部及び固相部から得られる抽出物と同等
のものとして含まれる。
On the other hand, the solid phase part obtained by squeezing olive fruit refers to a squeezed residue other than the liquid phase part obtained in the olive fruit squeezing step. In the present invention, an extract obtained by using water and / or an organic solvent as an extraction solvent is used as the extract of the present invention in the aqueous solution portion and the solid phase portion. Preferred organic solvents are hydrophilic alcohols such as ethyl alcohol, isopropyl alcohol, 1,3-butylene glycol, propylene glycol, polyhydric alcohols, etc., and a mixed solvent of these organic solvents and water. It is also possible to use it. The obtained extract can be used directly, or a product obtained by concentrating or drying the separated and purified product by a conventional method. In addition, the extract obtained by the said extraction method from the solid-phase part obtained by squeezing the fruit of olive is also included as an equivalent to the extract obtained from the aqueous solution part and solid-phase part of this invention.
本発明に係わる、オリーブの果実を圧搾して得られる水溶液部、又はオリーブの果実を圧搾して得られる水溶液部及び固相部より水及び/又は有機溶媒を用い抽出して得られる抽出物を含む紫外線傷害予防剤及びそれを含む飲食品組成物は、必要に応じその効果を損なわない範囲で、一般に飲食品組成物に使用される各種成分、すなわちビタミンC、ビタミンE、ビタミンB2、ビタミンB6、ニコチン酸アミド等のビタミン類、マグネシウム、亜鉛、クロム等のミネラル類、バナバ、ギムネマ、アロエ、ラカンカ、マコモ、クワの葉、ビワの葉、荷葉、サラシア、紅景天、難消化性デキストリン、石蓮花、茶ポリフェノール、テアニン、ヒスチジン、高麗ニンジン、海藻、ホップ、カイアポイモ、ビール酵母等を配合することができる。また乳化剤、分散剤、懸濁剤、展着剤、浸透剤、湿潤剤、安定剤等を組み合わせて配合することもできる。そして本発明は錠剤、顆粒剤、各種カプセル剤、ドリンク製剤、固形剤等、任意の剤型とすることができる。飲食物としては、飲料、ゼリー、チューインガム、キャンディ、錠菓等が挙げられるが、これらに限定されるものではない。 An aqueous solution part obtained by squeezing olive fruit according to the present invention, or an extract obtained by extracting water and / or an organic solvent from an aqueous solution part obtained by squeezing olive fruit and a solid phase part The ultraviolet ray injury preventive agent and the food / beverage product composition containing the same are various components generally used in the food / beverage food product composition, that is, vitamin C, vitamin E, vitamin B2, vitamin B6, as long as the effect is not impaired as required. , Vitamins such as nicotinamide, minerals such as magnesium, zinc, chromium, banaba, gymnema, aloe, lacanca, macomo, mulberry leaves, loquat leaves, cargo leaves, salasia, red scenic, indigestible dextrin, Stone lotus flowers, tea polyphenols, theanine, histidine, ginseng, seaweed, hops, silkworm, brewer's yeast, etc. can be blended. Further, an emulsifier, a dispersant, a suspending agent, a spreading agent, a penetrating agent, a wetting agent, a stabilizer and the like can be combined. And this invention can be made into arbitrary dosage forms, such as a tablet, a granule, various capsules, a drink formulation, a solid agent. Examples of the food and drink include, but are not limited to, beverages, jelly, chewing gum, candy, and tablet confectionery.
なお本発明の紫外線傷害予防剤を、飲食品組成物として供する場合の「オリーブ果実抽出物等」の配合量は、剤型により適宜選定されるべきものであり一概に規定することはできないが、一般には乾固物換算で、飲食品組成物全体を基準として、好ましくは0.01〜70質量%、特に好ましくは0.01〜50質量%配合させる。配合量が0.01質量%未満では、紫外線傷害予防効果が十分発揮されない場合がある。 Note that the amount of `` olive fruit extract etc. '' in the case where the ultraviolet ray injury preventive agent of the present invention is provided as a food or drink composition should be appropriately selected according to the dosage form and cannot be generally defined, In general, it is preferably 0.01 to 70% by mass, and particularly preferably 0.01 to 50% by mass, based on the whole food / beverage product composition, in terms of dried solids. If the blending amount is less than 0.01% by mass, the ultraviolet ray injury preventing effect may not be sufficiently exhibited.
本発明の飲食品組成物を経口摂取させる場合、「オリーブ果実抽出物等」を乾固物換算で、1日当たり好ましくは0.05〜1.0g、特に好ましくは0.08〜0.5g摂取させる。この範囲であれば、紫外線傷害予防効果が効率的に発揮させることができ、且つ無理なく継続的に摂取させることが可能である。また、日常的に紫外線傷害予防効果を発揮させるためにも、生活環境やレジャー予定等に合わせて、前記摂取を継続的に、好ましくは1週間以上継続的に摂取させることが好ましい。 When the food or beverage composition of the present invention is orally ingested, the “olive fruit extract and the like” is preferably 0.05 to 1.0 g, particularly preferably 0.08 to 0.5 g per day in terms of dried solid matter. Let If it is this range, the ultraviolet-ray injury prevention effect can be exhibited efficiently, and it can be made to ingest continuously without difficulty. Moreover, in order to exhibit the effect of preventing UV damage on a daily basis, it is preferable to continuously take the above-mentioned intake, preferably for one week or longer, according to the living environment, leisure schedule, and the like.
以下、実施例を挙げて本発明を詳細に説明するが、本発明はこれらによって限定されるものではない。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated in detail, this invention is not limited by these.
製造例1(オリーブの果実を圧搾して得られる水溶液部とその濃縮物の製造例)
Coratina種のオリーブ果実を用いるオリーブ油製造過程において得られた水溶液部8リットルに、未変性エタノール2リットルを加えた。得られたエタノール水溶液部を4℃、回転数10000rpmにて15分間遠心分離を行い、約1.5kgの固形物と約8.5リットルの水層部とに分離した。得られた水層部を定法に従い、セライトろ過することにより淡褐色の水溶液部(「製造例1水溶液部」)を約8.5リットル得た。また得られた「製造例1水溶液部」から5リットルを常法により濃縮し、濃縮物(「製造例1濃縮物」)を約220g得た。
Production Example 1 (Production example of an aqueous solution obtained by pressing olive fruit and its concentrate)
2 liters of unmodified ethanol was added to 8 liters of the aqueous solution obtained in the process of producing olive oil using Coratina olive fruits. The obtained aqueous ethanol solution was centrifuged at 4 ° C. and a rotation speed of 10,000 rpm for 15 minutes to separate into about 1.5 kg of solid matter and about 8.5 liters of an aqueous layer. About 8.5 liters of light brown aqueous solution part ("Production example 1 aqueous solution part") was obtained by carrying out Celite filtration of the obtained water layer part according to a usual method. Further, 5 liters of the obtained “Production Example 1 aqueous solution” was concentrated by a conventional method to obtain about 220 g of a concentrate (“Production Example 1 concentrate”).
製造例2(オリーブの果実を圧搾して得られる水溶液部の乾固物の製造例)
「製造例1濃縮物」から74.8gを凍結乾燥し、乾固物34.84gを得た(「製造例2乾固物」)。
Production Example 2 (Production example of dried product of aqueous solution obtained by pressing olive fruit)
From the “Production Example 1 concentrate”, 74.8 g was freeze-dried to obtain 34.84 g of a dried product (“Production Example 2 dried product”).
製造例3(オリーブ果実の水溶液部及び固相部由来の抽出物の製造例)
Coratina種のオリーブ果実2kgを圧搾し、得られた水溶液部および固相部に含水エタノールを加え、2回抽出した。得られた抽出液を定法にて濃縮し、乾固物100gを得た(「製造例3乾固物」)。
Production Example 3 (Production example of an extract derived from an aqueous solution part and a solid phase part of olive fruit)
2 kg of Coratina olive fruit was squeezed, and water-containing ethanol was added to the obtained aqueous solution part and solid phase part to extract twice. The obtained extract was concentrated by a conventional method to obtain 100 g of a dried product (“Production Example 3 dried product”).
実施例1(「製造例3乾固物」を含有する錠剤)
下記配合組成で、「製造例3乾固物」を含有する錠剤を常法に従って調製した。
Example 1 (Tablet containing "Production Example 3 dried product")
A tablet containing “Production Example 3 dried product” having the following composition was prepared according to a conventional method.
―――――――――――――――――――――
配合成分 配合率(質量%)
―――――――――――――――――――――
(1) 「製造例3乾固物」 7.0
(2) デキストリン 33.0
(3) 粉末マビット 30.0
(4) 結晶セルロース 23.0
(5) 寒天末 4.0
(6) 香 料 1.0
(7) ショ糖脂肪酸エステル 2.0
―――――――――――――――――――――
―――――――――――――――――――――
Blending ingredients Blending ratio (% by mass)
―――――――――――――――――――――
(1) "Production Example 3 dried product" 7.0
(2) Dextrin 33.0
(3) Powder Mabit 30.0
(4) Crystalline cellulose 23.0
(5) Agar powder 4.0
(6) Perfume 1.0
(7) Sucrose fatty acid ester 2.0
―――――――――――――――――――――
実施例2(紫外線により誘発される紅斑の抑制試験)
(試験方法)
1.健常人男性(13名)を被験者とし、背中を紫外線照射部位として行った。まず、試験開始時に、各被験者毎の最小紅斑量(Minimum Erythema Dose:MED)を測定した。背中に紫外線照射部位として7.5mm×7.5mmを10箇所設定した。紫外線照射装置デルマレイ(M−DMR−100、クリニカルサプライ)を用い、照射ランプとしてUVB:FL20S・E(TOREX)、UVA:S・BL(TOREX)を並列に並べて装着し、紫外線を照射した。その紫外線強度を、紫外線強度計(UVR−305/360−D(II)、TOREX)を用いて測定したところ、UVBは0.45mW/cm2であった。上記紫外線照射部位に照射時間を変えて紫外線を照射し、照射24時間後、専門判定員による判定により、各被験者のMEDを決定した。
2.被験者13名を無作為に10名と3名の2群に分け、10名には実施例1で作製した錠剤(200mg/錠)を1日12錠の割合で4週間連続で経口摂取させた。摂取時間、方法等は各被験者の自由とした(1日当りの「製造例3乾固物」の摂取量としては0.168g)。一方、残り3名の被験者については、試験期間中にMEDの変動が無いことを確認する為、無摂取群とした。試験終了時に上記と同様にMEDを測定した。
Example 2 (Suppression test of erythema induced by ultraviolet rays)
(Test method)
1. Healthy males (13 persons) were used as subjects and the back was used as an ultraviolet irradiation site. First, at the start of the test, the minimum erythema dose (MED) for each subject was measured. Ten places of 7.5 mm × 7.5 mm were set on the back as ultraviolet irradiation sites. Using an ultraviolet irradiation device Delmale (M-DMR-100, clinical supply), UVB: FL20S · E (TOREX) and UVA: S · BL (TOREX) were mounted in parallel as irradiation lamps, and ultraviolet rays were irradiated. When the ultraviolet intensity was measured using an ultraviolet intensity meter (UVR-305 / 360-D (II), TOREX), the UVB was 0.45 mW / cm 2 . The ultraviolet irradiation site was irradiated with ultraviolet rays while changing the irradiation time. After 24 hours of irradiation, the MED of each subject was determined by determination by a specialist judge.
2. Thirteen subjects were randomly divided into two groups of 10 and 3 and 10 were orally ingested with the tablets prepared in Example 1 (200 mg / tablet) at a rate of 12 tablets per day for 4 consecutive weeks. . The intake time, method, and the like were free for each subject (the intake of “Production Example 3 dried product” per day was 0.168 g). On the other hand, the remaining three subjects were assigned to the no-ingestion group in order to confirm that there was no change in MED during the test period. At the end of the test, the MED was measured as described above.
(結果)
試験結果を図1に示す。錠剤無摂取群では試験の前後においてMEDの変化はなかったのに対し、実施例1で作製した錠剤を4週間連続経口摂取させた摂取群では、摂取前と比較して有意にMEDが上昇した(p<0.01)。つまり、本発明実施例1の錠剤を4週間経口摂取することにより、紫外線により引き起こされる炎症が抑制されることが明らかになった。このことは、紫外線に対する抵抗力が増大したことを意味する。
(result)
The test results are shown in FIG. There was no change in MED before and after the test in the tablet non-intake group, whereas in the ingestion group in which the tablet prepared in Example 1 was orally ingested for 4 consecutive weeks, the MED significantly increased compared to before the ingestion. (P <0.01). That is, it was revealed that inflammation caused by ultraviolet rays is suppressed by ingesting the tablet of Example 1 of the present invention for 4 weeks. This means that the resistance to ultraviolet rays has increased.
本発明は、各種の紫外線傷害予防効果を有する飲食品組成物を提供することができる。以下にその例を挙げるが、本発明はこれらに限定されるものではない。 This invention can provide the food-drinks composition which has various ultraviolet-ray injury prevention effects. Examples thereof are given below, but the present invention is not limited thereto.
実施例3(錠剤)
―――――――――――――――――――――
配合成分 配合率(質量%)
―――――――――――――――――――――
(1) 「製造例3乾固物」 50.0
(2) デキストリン 20.0
(3) 結晶セルロース 23.0
(4) 寒天末 4.0
(5) 香料 1.0
(6) ショ糖脂肪酸エステル 2.0
―――――――――――――――――――――
上記の各成分を均一に混合し、常法により錠剤を調製した。
Example 3 (tablets)
―――――――――――――――――――――
Blending ingredients Blending ratio (% by mass)
―――――――――――――――――――――
(1) "Production Example 3 dried product" 50.0
(2) Dextrin 20.0
(3) Crystalline cellulose 23.0
(4) Agar powder 4.0
(5) Fragrance 1.0
(6) Sucrose fatty acid ester 2.0
―――――――――――――――――――――
Each of the above components was mixed uniformly, and a tablet was prepared by a conventional method.
実施例4(顆粒剤)
―――――――――――――――――――――
配合成分 配合率(質量%)
―――――――――――――――――――――
(1) 「製造例3乾固物」 20.0
(2) でんぷん 30.0
(3) 乳糖 49.0
(4) 結晶セルロース 1.0
―――――――――――――――――――――
上記の各成分を均一に粉砕混合し、常法により顆粒剤を調製した。
Example 4 (granule)
―――――――――――――――――――――
Blending ingredients Blending ratio (% by mass)
―――――――――――――――――――――
(1) "Production Example 3 dried product" 20.0
(2) Starch 30.0
(3) Lactose 49.0
(4) Crystalline cellulose 1.0
―――――――――――――――――――――
Each of the above components was uniformly pulverized and mixed to prepare granules.
実施例5(ソフトカプセル剤)
――――――――――――――――――――――
配合成分 配合率(質量%)
――――――――――――――――――――――
(1) 「製造例1濃縮物」 30.0
(2) 大豆油 25.0
(3) ビタミンE 20.0
(4) 小麦胚芽油 15.0
(5) グリセリン脂肪酸エステル 5.0
(6) ミツロウ 5.0
――――――――――――――――――――――
上記の各成分を混合し、ゼラチン、グリセリンからなるゼラチン皮膜に充填し、常法によりソフトカプセル剤とした。
Example 5 (soft capsule)
――――――――――――――――――――――
Blending ingredients Blending ratio (% by mass)
――――――――――――――――――――――
(1) “Production Example 1 Concentrate” 30.0
(2) Soybean oil 25.0
(3) Vitamin E 20.0
(4) Wheat germ oil 15.0
(5) Glycerin fatty acid ester 5.0
(6) Beeswax 5.0
――――――――――――――――――――――
Each of the above components was mixed and filled into a gelatin film composed of gelatin and glycerin to obtain a soft capsule by a conventional method.
実施例6(ハードカプセル剤)
――――――――――――――――――――――
配合成分 配合率(質量%)
――――――――――――――――――――――
(1) 「製造例2乾固物」 30.0
(2) 粉糖 45.0
(3) デキストリン 24.0
(4) グリセリン脂肪酸エステル 1.0
――――――――――――――――――――――
上記の各成分を混合し、ゼラチンからなるカプセル容器に充填し、常法によりハードカプセル剤とした。
Example 6 (hard capsule)
――――――――――――――――――――――
Blending ingredients Blending ratio (% by mass)
――――――――――――――――――――――
(1) "Production Example 2 dried product" 30.0
(2) Powdered sugar 45.0
(3) Dextrin 24.0
(4) Glycerin fatty acid ester 1.0
――――――――――――――――――――――
The above components were mixed and filled into a capsule container made of gelatin to obtain a hard capsule by a conventional method.
実施例7(ドリンク剤)
―――――――――――――――――――――
配合成分 配合率(質量%)
―――――――――――――――――――――
(1) 「製造例3乾固物」 1.5
(2) 還元麦芽糖水飴 20.0
(3) エリスリトール 10.0
(4) クエン酸 1.0
(5) 水 残 分
―――――――――――――――――――――
上記の各成分を混合し、常法によりドリンク剤とした。
Example 7 (drink preparation)
―――――――――――――――――――――
Blending ingredients Blending ratio (% by mass)
―――――――――――――――――――――
(1) "Production Example 3 dried product" 1.5
(2) Reduced maltose starch syrup 20.0
(3) Erythritol 10.0
(4) Citric acid 1.0
(5) Water residue ―――――――――――――――――――――
The above components were mixed and used as a drink by a conventional method.
実施例8(ゼリー製剤)
―――――――――――――――――――――
配合成分 配合率(質量%)
―――――――――――――――――――――
(1) 「製造例3乾固物」 0.1
(2) デキストリン 24.0
(3) パラチノース 5.0
(4) ゼラチン 1.0
(5) ペクチン 0.5
(6) イノシトール 5.0
(7) クエン酸 0.8
(8) アスコルビン酸 3.0
(9) ニコチン酸アミド 0.01
(10)水 残 分
―――――――――――――――――――――
上記の各成分を混合し、常法によりゼリー製剤とした。
Example 8 (jelly preparation)
―――――――――――――――――――――
Blending ingredients Blending ratio (% by mass)
―――――――――――――――――――――
(1) "Production Example 3 dried product" 0.1
(2) Dextrin 24.0
(3) Palatinose 5.0
(4) Gelatin 1.0
(5) Pectin 0.5
(6) Inositol 5.0
(7) Citric acid 0.8
(8) Ascorbic acid 3.0
(9) Nicotinamide 0.01
(10) Remaining water ―――――――――――――――――――――
Said each component was mixed and it was set as the jelly formulation by the conventional method.
実施例9(チューインガム)
―――――――――――――――――――――
配合成分 配合率(質量%)
―――――――――――――――――――――
(1) 「製造例2乾固物」 5.0
(2) ガムベース 25.0
(3) マルチトール 45.0
(4) マンニット 20.0
(5) ソルビトール 5.0
(6) 香料 1.0
(7) 水 残 分
―――――――――――――――――――――
上記の各成分を混合し、常法によりチューインガムを調製した。
Example 9 (chewing gum)
―――――――――――――――――――――
Blending ingredients Blending ratio (% by mass)
―――――――――――――――――――――
(1) "Production Example 2 dried product" 5.0
(2) Gum base 25.0
(3) Maltitol 45.0
(4) Mannit 20.0
(5) Sorbitol 5.0
(6) Fragrance 1.0
(7) Water residue ―――――――――――――――――――――
The above ingredients were mixed and a chewing gum was prepared by a conventional method.
実施例10(グミキャンディ)
―――――――――――――――――――――
配合成分 配合率(質量%)
―――――――――――――――――――――
(1) 「製造例3乾固物」 5.0
(2) グラニュー糖 34.0
(3) 水飴 30.0
(4) ゼラチン 10.0
(5) クエン酸 0.5
(6) 酒石酸 0.3
(7) 香料 1.0
(8) 水 残 分
―――――――――――――――――――――
上記の各成分を均一に粉砕混合し、常法によりグミキャンディを調製した。
Example 10 (Gummy Candy)
―――――――――――――――――――――
Blending ingredients Blending ratio (% by mass)
―――――――――――――――――――――
(1) "Production Example 3 dried product" 5.0
(2) Granulated sugar 34.0
(3) Minamata 30.0
(4) Gelatin 10.0
(5) Citric acid 0.5
(6) Tartaric acid 0.3
(7) Fragrance 1.0
(8) Water residue ―――――――――――――――――――――
The above components were uniformly pulverized and mixed to prepare gummy candy by a conventional method.
以上記載の如く、本発明に係る、オリーブの果実を圧搾して得られる水溶液部、又はオリーブの果実を圧搾して得られる水溶液部及び固相部より水及び/又は有機溶媒を用い抽出して得られる抽出物が、紫外線傷害予防剤として高い紫外線傷害予防効果を示すことは明らかであり、紫外線傷害予防機能を有する各種の飲食品組成物を提供できることは明らかである。 As described above, according to the present invention, water and / or an organic solvent is used for extraction from an aqueous solution part obtained by squeezing olive fruit, or an aqueous solution part obtained by squeezing olive fruit and a solid phase part. It is clear that the obtained extract exhibits a high ultraviolet ray injury preventing effect as an ultraviolet ray injury preventive agent, and it is clear that various food and drink compositions having an ultraviolet ray injury preventing function can be provided.
Claims (5)
An aqueous solution part obtained by squeezing olive fruit, or an aqueous solution part obtained by squeezing olive fruit and a solid phase, wherein the ultraviolet ray injury preventive agent according to claim 1 or 2 is blended in a food or drink composition A method of ingesting 0.05 to 1.0 g of an extract obtained by extracting water and / or an organic solvent from a part per day on a dry solid basis.
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005035234A JP2006219433A (en) | 2005-02-10 | 2005-02-10 | Agent for preventing ultraviolet hazard |
KR1020077017426A KR20070117544A (en) | 2005-02-10 | 2006-02-07 | Oral composition for the prevention of uv damages |
AU2006212481A AU2006212481A1 (en) | 2005-02-10 | 2006-02-07 | Oral compositions for the prevention of UV damages |
EP06706700A EP1845801A1 (en) | 2005-02-10 | 2006-02-07 | Oral compositions for the prevention of uv damages |
CNA200680004510XA CN101119642A (en) | 2005-02-10 | 2006-02-07 | Oral composition for the prevention of uv damages |
PCT/EP2006/001048 WO2006084658A1 (en) | 2005-02-10 | 2006-02-07 | Oral compositions for the prevention of uv damages |
US11/884,065 US20080260880A1 (en) | 2005-02-10 | 2006-02-07 | Oral Compositions for the Prevention of Uv Damages |
CA002597432A CA2597432A1 (en) | 2005-02-10 | 2006-02-07 | Oral compositions for the prevention of uv damages |
RU2007130551/15A RU2007130551A (en) | 2005-02-10 | 2006-02-07 | ORAL COMPOSITIONS FOR PREVENTING UV DAMAGE DAMAGE |
NO20074136A NO20074136L (en) | 2005-02-10 | 2007-08-09 | Oral compositions for the prevention of UV damage |
IL185136A IL185136A0 (en) | 2005-02-10 | 2007-08-09 | Oral compositions for the prevention of uv damages |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005035234A JP2006219433A (en) | 2005-02-10 | 2005-02-10 | Agent for preventing ultraviolet hazard |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006219433A true JP2006219433A (en) | 2006-08-24 |
Family
ID=36088283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005035234A Pending JP2006219433A (en) | 2005-02-10 | 2005-02-10 | Agent for preventing ultraviolet hazard |
Country Status (11)
Country | Link |
---|---|
US (1) | US20080260880A1 (en) |
EP (1) | EP1845801A1 (en) |
JP (1) | JP2006219433A (en) |
KR (1) | KR20070117544A (en) |
CN (1) | CN101119642A (en) |
AU (1) | AU2006212481A1 (en) |
CA (1) | CA2597432A1 (en) |
IL (1) | IL185136A0 (en) |
NO (1) | NO20074136L (en) |
RU (1) | RU2007130551A (en) |
WO (1) | WO2006084658A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010536353A (en) * | 2007-08-21 | 2010-12-02 | ディーエスエム アイピー アセッツ ビー.ブイ. | Method for producing olive juice extract containing reduced solids |
JP2013501512A (en) * | 2009-08-11 | 2013-01-17 | トトュム ビオ コスメティック | Method for producing whole olive juice, composition obtained by the method, and use of the composition in cosmetics and nutritional foods |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108244572A (en) * | 2018-02-09 | 2018-07-06 | 米盈食品科技(苏州)有限公司 | Have effects that whitening and prebiotics without sucrose jelly item and preparation method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06234623A (en) * | 1993-02-12 | 1994-08-23 | Maruzen Pharmaceut Co Ltd | Skin care cosmetic |
JP2001181197A (en) * | 1999-10-14 | 2001-07-03 | Nisshin Oil Mills Ltd:The | Olive extract |
JP2001252054A (en) * | 2000-01-07 | 2001-09-18 | Kanebo Ltd | Food composition |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3723487A (en) * | 1970-07-14 | 1973-03-27 | R Couche | Process for extracting oil from palm fruits and olives |
FR2712463B1 (en) * | 1994-03-03 | 1996-03-22 | Arkopharma Laboratoires | Fruit juice and suspension, their preparation process and their applications. |
AU746712B2 (en) * | 1998-07-23 | 2002-05-02 | Creagri, Inc. | Water-soluble extract from olives |
KR20020063877A (en) * | 1999-10-14 | 2002-08-05 | 니신 오일 밀스 가부시키가이샤 | Skin-care agents, skin antiaging agents, whitening agents and external skin preparations |
US6358542B2 (en) * | 1999-12-20 | 2002-03-19 | Usana, Inc. | Antioxidant compositions extracted from olives and olive by-products |
CA2420893C (en) * | 2000-09-01 | 2011-11-22 | Creagri, Inc. | Method of obtaining a hydroxytyrosol-rich composition from vegetation water |
KR20030064799A (en) * | 2000-11-30 | 2003-08-02 | 닛신 오일리오 가부시키가이샤 | Beautifying foods and drinks and peroral beautifying preparations |
FR2825022B1 (en) * | 2001-05-23 | 2005-01-14 | Seppic Sa | COMPOSITION OF OLIVE POLYPHENOLS. USE AS A COSMETIC AND DIETETIC ACTIVE |
US8216599B2 (en) * | 2002-02-13 | 2012-07-10 | Creagri, Inc. | Method for treatment of inflammation |
JP2004315391A (en) * | 2003-04-14 | 2004-11-11 | Shodoshima Healty Land Kk | Olive fruit extract and method for producing the same |
FR2863166B1 (en) * | 2003-12-05 | 2006-02-24 | Silab Sa | PROCESS FOR OBTAINING ACTIVE INGREDIENT BASED ON OLIVE PEAT AND ACTIVE INGREDIENT |
FR2867071B1 (en) * | 2004-03-02 | 2006-06-09 | Occitane L | COSMETIC OR DERMATOLOGICAL COMPOSITION BASED ON OLIVE |
-
2005
- 2005-02-10 JP JP2005035234A patent/JP2006219433A/en active Pending
-
2006
- 2006-02-07 CN CNA200680004510XA patent/CN101119642A/en active Pending
- 2006-02-07 US US11/884,065 patent/US20080260880A1/en not_active Abandoned
- 2006-02-07 WO PCT/EP2006/001048 patent/WO2006084658A1/en active Application Filing
- 2006-02-07 AU AU2006212481A patent/AU2006212481A1/en not_active Abandoned
- 2006-02-07 RU RU2007130551/15A patent/RU2007130551A/en not_active Application Discontinuation
- 2006-02-07 EP EP06706700A patent/EP1845801A1/en not_active Withdrawn
- 2006-02-07 CA CA002597432A patent/CA2597432A1/en not_active Abandoned
- 2006-02-07 KR KR1020077017426A patent/KR20070117544A/en not_active Application Discontinuation
-
2007
- 2007-08-09 IL IL185136A patent/IL185136A0/en unknown
- 2007-08-09 NO NO20074136A patent/NO20074136L/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06234623A (en) * | 1993-02-12 | 1994-08-23 | Maruzen Pharmaceut Co Ltd | Skin care cosmetic |
JP2001181197A (en) * | 1999-10-14 | 2001-07-03 | Nisshin Oil Mills Ltd:The | Olive extract |
JP2001252054A (en) * | 2000-01-07 | 2001-09-18 | Kanebo Ltd | Food composition |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010536353A (en) * | 2007-08-21 | 2010-12-02 | ディーエスエム アイピー アセッツ ビー.ブイ. | Method for producing olive juice extract containing reduced solids |
JP2013501512A (en) * | 2009-08-11 | 2013-01-17 | トトュム ビオ コスメティック | Method for producing whole olive juice, composition obtained by the method, and use of the composition in cosmetics and nutritional foods |
Also Published As
Publication number | Publication date |
---|---|
CA2597432A1 (en) | 2006-08-17 |
IL185136A0 (en) | 2008-12-29 |
EP1845801A1 (en) | 2007-10-24 |
NO20074136L (en) | 2007-09-10 |
WO2006084658A1 (en) | 2006-08-17 |
AU2006212481A1 (en) | 2006-08-17 |
US20080260880A1 (en) | 2008-10-23 |
CN101119642A (en) | 2008-02-06 |
RU2007130551A (en) | 2009-02-20 |
KR20070117544A (en) | 2007-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8883225B2 (en) | Water-soluble pharmaceutical compositions of hops resins | |
CA2559416A1 (en) | Composition for oral cavity | |
JP2006306804A (en) | Wrinkle formation inhibitor | |
WO2018147718A2 (en) | Cocoa pericarp compositions and method for producing same | |
JP2006016390A (en) | Proanthocyanidin-containing composition | |
JP2007145753A (en) | Lipase inhibitor | |
JP2005029486A (en) | Skin-improving composition | |
CA2863880A1 (en) | Eucommia ulmoides-containing chocolate compositions | |
US20090175968A1 (en) | Dietary compositions for promoting brain health | |
JP6981664B2 (en) | Nourishing tonic | |
KR101624704B1 (en) | Pharmaceutical composition and food composition for prevention, treatment or improvement of hair loss or benign prostatic hyperplasia | |
JP2006219433A (en) | Agent for preventing ultraviolet hazard | |
JP2001252054A (en) | Food composition | |
JP2010159283A (en) | Proanthocyanidin-containing composition | |
JP2009263332A (en) | Medicine containing olive leaf extract for maintaining health of periodontium | |
JP2005089374A (en) | Food and drink having function for preventing increase in blood glucose level | |
JPH09143086A (en) | Drug and cosmetic for treatment of skin disease | |
JP5004529B2 (en) | Histamine release inhibitor | |
KR20180111016A (en) | Composition for preventing, improving, or treating dermatitis comprising oil or hydrosol from plant as effective component | |
KR101610894B1 (en) | Taste-masked granules containing vitamin C | |
JP2005060338A (en) | Proanthocyanidin-including composition | |
JP2011121920A (en) | Elastase inhibitor, and cosmetic composition and pharmaceutical composition comprising the same | |
JP2009242273A (en) | Oral composition capable of lowering serum ldl cholesterol level | |
JP2019182863A (en) | Skin firmness or moisture improving composition | |
JP2002220333A (en) | Skin-whitening agent for oral intake |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070209 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20090424 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100622 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101019 |